PDF-Page 1 of 6 HFS Category 80:12 Meningococcal Polysaccharide Vaccine, G

Author : phoebe-click | Published Date : 2015-09-27

xMCIxD 0 xMCIxD 0 Page 2 of 6 ersons who have certain medical conditions are at increased risk for developing meningococcal infection Meningococcal disease is particularly

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Page 1 of 6 HFS Category 80:12 Meningoco..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Page 1 of 6 HFS Category 80:12 Meningococcal Polysaccharide Vaccine, G: Transcript


xMCIxD 0 xMCIxD 0 Page 2 of 6 ersons who have certain medical conditions are at increased risk for developing meningococcal infection Meningococcal disease is particularly common a. 1 What is meningococcal Meningococcal disease is a serious bacterial illness. It 2 live, another 11%–19% lose their arms or legs, have suffer seizures or strokes. from it, and many others are An Overview for Parents, Teachers, Students and Communities. 2013. Meningococcal Disease Fast Facts. Meningococcal disease is the result of a rare, but serious bacterial infection. It can occur as meningitis (inflammation of the lining of the brain and spinal cord), bacteremia (blood infection), or pneumonia. HFS 3082 (R-12-11) DOB: Nine-Digit HFS Recipient #: Name: Fax: NPI #: Phone:Prescriber information (required): Phone: Fax: NPI #: Pharmacy Name:Pharmacy information (required only when : Phone: Fax Sugata. Ray (University of Florida). Joint work with . Vikas. Agarwal (Georgia State University). Yan Lu (University of Florida). Motivation I. What is simultaneous management?. A HF and a FOF managed by the same parent company are defined as being simultaneously managed . Massachusetts requirements for meningococcal vaccinationMassachusetts law (MGL Ch. 76, s. 15D) and regulations (105 CMR 220.000) requires all newly enrolled fulltime students 21 years of age and under Serogroup B Meningococcal Disease F requently Asked Questions Adolescents and young adults are at increased risk of meningococcal disease , often referred to as meningitis , a serious disease that About the Know. Act. Prevent. In the case of Kimberly and Emily, while both had received the MenACWY vaccine, the MenB vaccine was not yet available to help protect them against Meningitis B 1 What is meningococcal Meningococcal disease is a serious bacterial illness. It 2 live, another 11%–19% lose their arms or legs, have suffer seizures or strokes. from it, and many others are Whogetsmeningococcalinvasivedisease?Althoughit can occurpeopleallages,infants, peoplegetmeningococcalinvasivedisease?Thebacteriaspreadfrompersonperson throughtheexchangesaliva(spit),coughs,sneezes.You 201 8 Louisiana Office of Public Health – Infectious Disease Epidemiology Section Page 1 of 10 Meningococcal Infections Neisse ria meningitidis invasive disease is a Class A Disease and must be r MENINGOCOCCAL INFECTIONS Agent: Neisseriameningitidis, a Gramnegative diplococcus. Identification Diagnosis: Positive culture or detection of N. meningitidisspecific nucleic acid from a normally steri threatening bloodstream infection (sepsis) or meningitis (infection of the lining around the brain), or both. It can attack without warning and SYMPTOMS include: WHAT IS MENINGOCOCCAL MENINGITIS Disease Who should get meningococcal vaccine? Adolescents are recommended to receive two doses of the meningococcal vaccine that prevents infection with types A, C, W, and Y. The first dose is rec Non Slip . Seal Coat – Christchurch Style. Aftershocks total = 2086 . May 6 2011 . Outline of Presentation. History. Failures. Modes of Failure. Adhesive Failure. Delamination Failure. Cohesive failure.

Download Document

Here is the link to download the presentation.
"Page 1 of 6 HFS Category 80:12 Meningococcal Polysaccharide Vaccine, G"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents